Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM new admission: Metals One pins hopes on Scandinavian battery metals projects

AIM movers: Victoria on course and Wishbone Gold raises exploration funds

IOG remains in talks with bondholders

AIM movers: Scancell trial expansion and Aptamer raises much-needed cash

Eden Research launches retail offer to shareholders

Interims could confirm Domino’s Pizza momentum

Aquis weekly movers: TruSpine Technologies FDA submission

AIM weekly movers: Itsarm bounces back

Vanquis Banking slumps on loss

AIM movers: AFC Energy generator revenues and WH Ireland secures rescue funds

Franchise Brands decides to retain consumer franchise brands

AIM movers: Safestyle slumps into loss and ex-dividends

NAV holding up at Picton Property Income

AIM movers: Actual Experience contract and Great Western Mining fundraising

Greatland Gold’s exploration progress

AIM movers: N4P patent grant and Wandisco slumps on return

AIM movers: Revolution Beauty investigation and new life for Itsarm

Upgrade potential for International Consolidated Airlines

New Aquis admission: Ora Technology

Aquis weekly movers: Cadence Minerals boost

AIM weekly movers: OptiBiotix Health sweetener

Why companies left AIM in June 2023

AIM movers: Filtronic ESA contract and Bowleven still planning fundraising

High debt masks Marstons value

Babcock International restructuring benefits

AIM movers: Brand Architekts cutting losses and ex-dividends

Argo Blockchain raises cash to reduce debt

AIM movers: OptiBiotix Health soars on SweetBiotix news and Watkin Jones warning

EY confirms Darktrace accounts

AIM movers: Arbuthnot Banking interest boost and CleanTech Lithium rally continues

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020